SYRE icon

Spyre Therapeutics
SYRE

Overview Fund Activity

43 hedge funds and large institutions have $31.9M invested in Spyre Therapeutics in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 16 closing their positions.

Holders
43
Holders Change
-1
Holders Change %
-2.27%
% of All Funds
0.68%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
15
Increased
4
Reduced
8
Closed
16
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$1K

Top Buyers

1
FFM
1
Fairmount Funds Management
Pennsylvania
$4.26M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$3.97M
3
VA
3
VR Adviser
New York
$2.86M
4
EC
4
EcoR1 Capital
California
$2.25M
5
AAA
5
Affinity Asset Advisors
New York
$2.21M

Top Sellers

1
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$0
2
SCM
2
Sio Capital Management
New York
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$292K
4
Millennium Management
4
Millennium Management
New York
$1.11M
5
O
5
OrbiMed
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
BCM
51
Bridgeway Capital Management
Texas
– -$43.5K -6,000 Closed
ECM
52
ExodusPoint Capital Management
New York
– -$34K -4,699 Closed
FSA
53
Franklin Street Advisors
North Carolina
– -$31K -4,232 Closed
William Blair & Company
54
William Blair & Company
Illinois
– -$17.5K -2,412 Closed
RWM
55
Ritholtz Wealth Management
New York
– -$12.1K -1,671 Closed
Bank of America
56
Bank of America
North Carolina
– -$10.2K -1,409 Closed
VF
57
Virtu Financial
New York
– -$6K -772 Closed
BNP Paribas Financial Markets
58
BNP Paribas Financial Markets
France
– -$115 -16 Closed
1 2
3